[Form 4] Kindly MD, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Kindly MD, Inc. (NAKA) insider reported multiple grants to Chief Medical Officer Timothy Pickett on 09/22/2025. The Form 4 shows four non‑derivative transactions reporting the receipt of 37,593 restricted stock units that vest over four years with a 12‑month cliff, plus three fully vested restricted stock awards of 26,129, 10,146, and 18,378 shares, bringing reported beneficial ownership to 191,271 shares after the transactions. All grants were reported with a $0 price, indicating they are equity awards rather than market purchases. The filing is signed by an attorney‑in‑fact on behalf of the reporting person.

Insights

Corporate Governance Expert

TL;DR: Routine executive equity grants with multi‑year vesting, aligning retention incentives with service.

The Form 4 documents customary equity compensation for the Chief Medical Officer consisting of time‑based restricted stock units and fully vested restricted awards. The 37,593 RSUs include a 12‑month cliff then quarterly vesting over three additional years, which is a standard retention structure intended to tie executive alignment to company performance and tenure. The awards were reported at $0, consistent with compensation grants rather than open‑market trades. From a governance perspective, these disclosures are routine and do not by themselves indicate unusual dilution or related‑party issues.

Securities Analyst

TL;DR: Non‑cash equity grants increase insider holdings but represent standard compensation, likely neutral for near‑term valuation.

The filing increases the reporting person’s beneficial ownership to 191,271 shares following the September 22, 2025 grants and vesting events. Because the transactions are equity awards reported at no cash price, they represent compensation expense and potential future dilution as RSUs vest, rather than immediate market buys or sales. Absent additional financial context (share count, recent dilution rates, or material corporate events), these transactions appear informational and routine for modeling long‑term share count impacts.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Pickett Timothy

(Last) (First) (Middle)

5097 SOUTH 900 EAST, SUITE 100

(Street)

SALT LAKE CITY UT 84117

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Kindly MD, Inc. [ NAKA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/22/2025		A		37,593(1)	A	$0	136,618	D
Common Stock	09/22/2025		A		26,129(2)	A	$0	162,747	D
Common Stock	09/22/2025		A		10,146(3)	A	$0	172,893	D
Common Stock	09/22/2025		A		18,378(4)	A	$0	191,271	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This reflects restricted stock units ("RSUs") that shall time-vest over a four (4) year period, with no vesting during the first twelve (12) months following August 15, 2025 (the "Cliff Period"), and thereafter twenty-five percent (25%) of the RSUs shall vest upon completion of the Cliff Period, with the remaining seventy-five percent (75%) of the RSUs vesting in equal quarterly installments over the subsequent thirty six (36) months, subject to the reporting person's continued service to the issuer through each applicable vesting date.

2. This reflects a restricted stock award that was fully vested as of September 22, 2025.

3. This reflects a restricted stock award that was fully vested as of September 22, 2025.

4. This reflects a restricted stock award that was fully vested as of September 22, 2025.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Kyle Simon, as attorney-in-fact	09/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions were reported for Kindly MD (NAKA)?

The Form 4 reports equity awards to Chief Medical Officer Timothy Pickett: 37,593 RSUs with time‑based vesting and three fully vested restricted stock awards of 26,129, 10,146, and 18,378 shares, all on 09/22/2025.

How do the reported RSUs vest for Timothy Pickett?

The 37,593 RSUs vest over four years with a 12‑month cliff ending August 15, 2026, then 25% vests at cliff and the remaining 75% vests in equal quarterly installments over the following 36 months.

What is the reported beneficial ownership after these transactions?

Following the reported transactions, the Form 4 shows the reporting person beneficially owns 191,271 shares.

Were any of the shares purchased at market price?

No. All reported transactions are recorded with a $0 price, indicating they are equity awards rather than open‑market purchases.

Who filed the Form 4 on behalf of the reporting person?

The Form 4 was signed and filed by Kyle Simon, as attorney‑in‑fact, on 09/24/2025.